As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Hi there! If you’re here, chances are you’re on a GLP-1 medication like Ozempic, Wegovy, or Mounjaro, and you’re looking ...
American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), Exxon Mobil ...
Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...